Last updated 14 days ago

A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC

420 patients around the world
Available in Brazil, United States
Janssen Research & Development, LLC
1Research sites
420Patients around the world
This study is for people with
Prostate cancer
Castration sensitive prostate cancer
Metastatic prostate cancer
Requirements for the patient
From 18 Years
Male
Medical requirements
Sites
Centro de Estudos e Pesquisas de Hematologia e Oncologia - CEPHO
Recruiting
Av. Príncipe de Gales, 821 - Vila Principe de Gales, Santo André - SP, 09060-650
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy